We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Canada-based Microbix Biosystems and Chicago's Angiogen have signed an agreement to commercialize a proprietary technology that has shown promise for treating prostate, colon and other human cancers, the companies have reported.
UK-based Oxford Genome Sciences has announced a collaboration with California's Biosite for the evaluation of protein-based disease markers for colorectal cancer.
China is expected to establish a nationwide medical insurance system by 2020 for all its residents, 75 per cent of whom are still lacking in health coverage, experts have reported.
Five years after a committee was inaugurated by the Nigerian Institute of Management (NIM) to find a veritable vaccine for malaria prevention, it is now evident that the project may not see the light of the day after all.
All countries need to take action to ensure that poor people, mainly in developing countries, have access to necessary medication, the World Health Organization (WHO) suggested on Monday.
The Health Minister today welcomed the announcement of a unique international collaboration with one of the world's largest pharmaceutical companies in a deal worth almost £50 million to create the world's first Translational Medicine Research Collaboration in Scotland.